Press release
Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis
Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have prompted a number of pharmaceutical companies to outsource their research operationsLondon
Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings.
Majority of the small companies as well as a few mid to large sized players, do not have the required capital or experience to undertake the development programs by themselves. Moreover, the costs associated with idle capacity for such specialized facilities are also high. As a result, the extent of outsourcing activities has considerably increased over the past few years.
To order this 290+ page report, which features 95+ figures and 130+ tables, please visit this link - https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
Key Market Insights
Presently, more than 520 players claim to offer contract research services
Nearly 70% of the players provide contract research services for conducting clinical trials, followed by those offering services concerning regulatory affairs management (49%). It is worth mentioning that 41 service providers claim to have the required expertise to serve as one-stop-shops to cater to the needs of various pharmaceutical firms.
Partnership activity within this domain has grown significantly, since 2018
In the last three years, more than 190 agreements were inked by the pharmaceutical contract research service providers, with maximum activity being reported in 2020. Majority of the instances were related to acquisitions (20%), clinical trial agreements (18%), R&D agreements (14%), and research agreements (12%).
Close to 50 mergers and acquisitions were established in this domain, during the period 2018-2021
It was observed that majority of the deals were intracontinental (76%), involving participants from the same countries. Geographical consolidation and service portfolio expansion were observed to the major key value drivers of M&A activity in this domain. This was followed by instances of service portfolio addition and geographical expansion.
At present, companies offering clinical stage services represent majority of the market share (in terms of sales revenues)
By 2030, the pharmaceutical contract research market in North America is estimated to be worth USD 29 billion, representing an annualized growth rate of 9.7%. It is worth mentioning that the market in Asia-pacific is anticipated to grow at a relatively faster pace, during the forecast period.
.
To request a sample copy / brochure of this report, please visit this link - https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
Key Questions Answered
Who are the leading players offering contract research services for small molecules?
Which partnership models are commonly adopted by stakeholders engaged in pharmaceutical contract research services market?
What are the key value drivers of the merger and acquisition activity observed within pharmaceutical contract research services market?
What are the likely future trends in contract research services market?
How is the current and future opportunity likely to be distributed across key market segments?
What is the total cost of ownership required to set up a pharmaceutical contract research organization?
The USD 59 billion (by 2030) financial opportunity within the pharmaceutical contract research service providers market has been analyzed across the following segments:
Scale of Operation
Discovery
Preclinical
Clinical
Target Therapeutic Area
Oncological Disorders
Infectious Diseases
Neurological Disorders
Inflammatory Disorders
Cardiovascular Disorders
Dermatological Disorders
Ophthalmic Diseases
Respiratory Disorders
Key Geographical Regions
North America
Europe
Asia- Pacific
Middle East
North Africa
Latin America
The report also features detailed profiles of key players (listed below); each profile features a brief overview of the company, its financial information (if available), information on the services offered and an informed future outlook.
Albany Molecular Research (AMRI)
BioDuro
BOC Sciences
Catalent Pharma
Charles River Laboratories
ChemDiv
Covance
Medpace
QPS
Concept Life Sciences
Evotec
ChemPartner
Pharmaron
Syngene
Torrent Pharma
WuXi AppTec
For additional details, please visit
https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Biospecimen Contract Research Services Market, 2021–2030
2. Biopharmaceutical CROs Market, 2021-2030
3. Cell and Gene Therapy CROs Market, 2021-2030
Contact:
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
ben.johnson@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis here
News-ID: 2433858 • Views: …
More Releases from Roots Analysis

Medical Aesthetics Market CAGR To Be Around 9.4% by 2035, Due To The Growing Dem …
According to our latest market report "Medical Aesthetics Market, Till 2035 by Type of Products and / or Devices Offered, Type of Procedure, End-user, Gender, Distribution Channel and Key Geographical Regions: Industry Trends and Global Forecasts", the global medical aesthetics market size is projected to reach USD 102 billion by 2035 from USD 35 billion in 2023, growing at a CAGR of 9.4% in the forecast period 2023-2035.
The increasing…

In Vitro Diagnostics Market Size to Hit USD 190 billion by 2035 | Exclusive Repo …
The In Vitro Diagnostics Market size was valued at USD 108 billion in 2024 and likely to hit over USD 190 billion by 2035, growing at a CAGR of 5.2% during the forecast period 2024 to 2035
In vitro diagnostics (IVD) are the tests conducted on samples retrieved from human body, such as blood, saliva or tissue in order to detect diseases or conditions. Such tests help diagnose, monitor, and manage…

Skincare Market Revenue to Cross USD 405 billion by 2035 | Roots Analysis
According to our latest market report "Skincare Market by Type of Product by Application, Type of Product by Body Part, Distribution Channel, Type of Offline Distribution Channel, Type of Packaging, Product Category, Gender, Type of Ingredient, and Geography: Industry Trends and Global Forecasts, till 2035", the global skincare market size is projected to reach USD 407 billion by 2035 from USD 185 billion in 2024, growing at a CAGR of…

Virtual Biopsy Market CAGR To Reach 14.47% by 2035, Due to Growing Demand for No …
According to our latest market report "Virtual Biopsy Market by Target Therapeutic Area, Type of Cancer Targeted, Type of Imaging Technology, End Users and Geographical Regions: Industry Trends and Global Forecasts, till 2035", the virtual biopsy market size is projected to reach USD 3.02 billion by 2035 from USD 0.78 billion in 2025, growing at a CAGR of 14.47% in the forecast period till 2035.
Biopsy procedure has been considered…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…